Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)

Academic Article

Published In

  • Annals of Oncology  Journal
  • Digital Object Identifier (doi)

    Author List

  • Cohen EEW; Algazi A; Laux D; Wong DJ; Amin A; Nabell L; Chisamore M; Gamelin E; Janssen R; Bishnoi S
  • Start Page

  • viii375
  • Volume

  • 29